Fertility Treatments Global Market Report 2023: Growth in the Median Age of First Time Motherhood Bolsters Sector – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Fertility Treatments Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering.

The global fertility treatments market is expected to grow from $14.13 billion in 2021 to $15.26 billion in 2022 at a compound annual growth rate (CAGR) of 8.0%. The fertility treatment market is expected to reach $21.04 billion in 2026 at a CAGR of 8.4%.

North America was the largest region in the fertility treatment market in 2022. Western Europe was the second largest region in the fertility treatment market. The regions covered in the fertility treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The growth in the median age of first-time motherhood combined with change in lifestyle increased the difficulty of conceiving, increasing the demand for fertility treatment. The median age of first-time motherhood has increased all over the globe due to late marriages, contraceptive techniques, and an increase in the number of women who prioritize their careers over starting a family.

In 2020, the average age of first-time mothers in America has risen from 21 to 26. Women in other developed countries are also deferring, with the typical first birth occurring at the age of 31 for new mothers. In this scenario, a growing number of women are opting for IVF treatments, which is expected to drive this market.

The high cost and low success rate of In vitro fertilization (IVF) treatment is a major factor that limits the growth of the fertility treatments market. In vitro fertilization is a fertilization process in which an egg is fertilized with sperm outside the body, in vitro. In vitro fertilization (IVF) treatment costs differ in many countries due to the lack of refund policies.

Moreover, insurance companies usually do not cover infertility treatments. According to the American society of reproductive medicine, in the USA, the average cost of an IVF cycle is $12,400 and the average cost of an IVF cycle using fresh embryos is $8,158 with a median cost at $7,500. The rate of success of IVF treatments is only 28% to 35%, which decreases with the increase in woman’s age. For example, for women, the success rate is 32.2% under 35 and 1.9% for women aged over 44. Thus, the high cost and low success rate of IVF treatment restrict the growth of the fertility treatment market.

Development of new techniques to treat infertility using a human’s body is a key trend in the fertility treatments market. INVOcell is an IVF alternative that uses the woman’s body to support fertilization, thus eliminating the cost of a laboratory incubator. The INVOcell device is placed with the eggs and sperm in the vaginal cavity, allowing for the stability of the natural environment, pH, and gas to help in fertilization. INVOcell, which is made in Medford, Massachusetts by INVO Bioscience, costs around $6,800 including medication. Although IVF generated more quality embryos, the birth rates between IVF and INVOcell are similar. According to the journal of assisted reproduction and genetics, 12 out of 20 women gave birth to 15 babies in IVF including three sets of twins and 11 out of 20 women gave birth to 16 babies in INVOcell group including five sets of twins.

In August 2022, CCRM Fertlity, an American fertility treatment company, acquired Institute for Reproductive Medicine & Sciences (IRMS) for an undisclosed amount. The acquisition would add world class proprietary reproductive medicine offerings to the CCRM’s portfolio and expand its footprint across 11 major metropolitan areas with 34 locations across the US and Canada. Institute for Reproductive Medicine and Science (IRMS) is a US-based fertility research and treatment company having its presence in major metropolitan areas.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Scope

Markets Covered:

1) By Product: Reagents; Equipment

2) By End-User: Fertility Clinics; Hospitals; Surgical Centers; Clinical Research Institutes

3) By Patient Type: Female; Male

Companies Mentioned: Apollo Hospitals Enterprise Ltd.; Care Fertility Group; Genea Limited; The Johns Hopkins Health System Corp; Medicover Group

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

A selection of companies mentioned in this report includes

• Apollo Hospitals Enterprise Ltd.
• Care Fertility Group
• Genea Limited
• The Johns Hopkins Health System Corp
• Medicover Group
• Monash IVF Group
• Progyny Inc.
• Vitrolife
• Carolinas Fertility Institute
• OvaScience Inc.
• Xytex Cryo International
• Merck KGaA
• Cook Medical
• CooperSurgical Inc.
• Instituto Bernabeu
• INVO Bioscience
• The Cooper Companies Inc.
• Virtus Health
• CryoChoice LLC
• Millendo Therapeutics Inc.
• FUJIFILM Irvine Scientific
• LABOTECT GMBH
• Fertility Focus
• Olympus Corporation
• Irvine Scientific sales Company Inc.
• Ferring Pharmaceuticals

For more information about this report visit https://www.researchandmarkets.com/r/1sozkj

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900